These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18505927)

  • 1. The biphasic role of the hypoxia-inducible factor prolyl-4-hydroxylase, PHD2, in modulating tumor-forming potential.
    Lee K A; Lynd JD; O'Reilly S; Kiupel M; McCormick JJ; LaPres JJ
    Mol Cancer Res; 2008 May; 6(5):829-42. PubMed ID: 18505927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
    Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
    Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
    Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
    Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer.
    Su Y; Loos M; Giese N; Metzen E; Büchler MW; Friess H; Kornberg A; Büchler P
    Cancer; 2012 Feb; 118(4):960-72. PubMed ID: 21792862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation.
    Takeda K; Fong GH
    Hypertension; 2007 Jan; 49(1):178-84. PubMed ID: 17101841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
    Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
    J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of prolyl hydroxylase 2 in the interference of aryl hydrocarbon receptor and hypoxia-inducible factor-1 alpha signaling.
    Seifert A; Katschinski DM; Tonack S; Fischer B; Navarrete Santos A
    Chem Res Toxicol; 2008 Feb; 21(2):341-8. PubMed ID: 18072750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.
    Barth S; Nesper J; Hasgall PA; Wirthner R; Nytko KJ; Edlich F; Katschinski DM; Stiehl DP; Wenger RH; Camenisch G
    Mol Cell Biol; 2007 May; 27(10):3758-68. PubMed ID: 17353276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assays to Study Hypoxia-Inducible Factor Prolyl Hydroxylase Domain 2 (PHD2), a Key Human Oxygen Sensing Protein.
    Chan YY; Mbenza NM; Chan MC; Leung IKH
    Methods Mol Biol; 2023; 2648():187-206. PubMed ID: 37039992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.
    Li Y; Zhang D; Wang X; Yao X; Ye C; Zhang S; Wang H; Chang C; Xia H; Wang YC; Fang J; Yan J; Ying H
    Sci Rep; 2015 Jul; 5():12495. PubMed ID: 26205124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of hypoxia-inducible factor prolyl hydoxylase-2 attenuates hypoxia-induced vascular endothelial growth factor expression in luteal cells.
    Zhang Z; Pang X; Tang Z; Yin D; Wang Z
    Mol Med Rep; 2015 Sep; 12(3):3809-3814. PubMed ID: 25975603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHD2 in tumour angiogenesis.
    Chan DA; Giaccia AJ
    Br J Cancer; 2010 Jun; 103(1):1-5. PubMed ID: 20461086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the cellular oxygen sensor PHD2 (EGLN-1) predicts radiation sensitivity in squamous cell cancer of the head and neck.
    Luukkaa M; Jokilehto T; Kronqvist P; Vahlberg T; Grénman R; Jaakkola P; Minn H
    Int J Radiat Biol; 2009; 85(10):900-8. PubMed ID: 19639506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.
    Dayan F; Roux D; Brahimi-Horn MC; Pouyssegur J; Mazure NM
    Cancer Res; 2006 Apr; 66(7):3688-98. PubMed ID: 16585195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short hairpin RNA interference therapy for ischemic heart disease.
    Huang M; Chan DA; Jia F; Xie X; Li Z; Hoyt G; Robbins RC; Chen X; Giaccia AJ; Wu JC
    Circulation; 2008 Sep; 118(14 Suppl):S226-33. PubMed ID: 18824759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
    Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
    Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
    Berra E; Benizri E; Ginouvès A; Volmat V; Roux D; Pouysségur J
    EMBO J; 2003 Aug; 22(16):4082-90. PubMed ID: 12912907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of prolyl-4-hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA-MB-231 cells by affecting TGF-β1 processing.
    Wottawa M; Leisering P; Ahlen Mv; Schnelle M; Vogel S; Malz C; Bordoli MR; Camenisch G; Hesse A; Napp J; Alves F; Kristiansen G; Farhat K; Katschinski DM
    Int J Cancer; 2013 Jun; 132(12):2787-98. PubMed ID: 23225569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.